• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Study on the antidiuretic efficacy and mechanism of indapamide in central diabetes insipidus].

作者信息

Peng H, Zhou Z, Zhao W, Wu H

机构信息

Institute of Metabolism & Endocrinology, Second Affiliated Hospital, Hunan Medical University, Changsha 410011.

出版信息

Hunan Yi Ke Da Xue Xue Bao. 1999;24(3):259-62.

PMID:12016800
Abstract

OBJECTIVE

To investigate the efficacy and antidiuretic mechanism of indapamide in central diabetes insipidus.

METHODS

We observed eight patients with central diabetes insipidus treated by indapamide (2.5-7.5 mg.d-1) or dihydro-chlorothiazide (50-70 mg.d-1) or carbamazepine (150-300 mg.d-1) for 8 days with randomized block design. The therapy was changed twice in sequence after 4 days without treatment. Urine output and indexes of water metabolism were also observed.

RESULTS

The urine output was reduced on the 4th day and 8th day with each therapy. The serum potassium and chloride concentration was decreased and renin activity was increased on the 4th and 8th day with indapamide therapy.

CONCLUSION

Indapamide has antidiuretic action on central diabetes insipidus. The action may result from the changes of hydroelectrolytes and renin-angiotensin-aldosterone system.

摘要

相似文献

1
[Study on the antidiuretic efficacy and mechanism of indapamide in central diabetes insipidus].
Hunan Yi Ke Da Xue Xue Bao. 1999;24(3):259-62.
2
[Clinical trial of indapamide in the management of central diabetes insipidus].吲达帕胺治疗中枢性尿崩症的临床试验
Zhonghua Nei Ke Za Zhi. 1994 Oct;33(10):661-2.
3
[Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension].螺内酯与吲达帕胺在低肾素性动脉高血压治疗中的应用
Ter Arkh. 2006;78(2):61-4.
4
Efficacy of indapamide in central diabetes insipidus.
Arch Intern Med. 1999 Sep 27;159(17):2085-7. doi: 10.1001/archinte.159.17.2085.
5
Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.阿仑膦酸钠与吲达帕胺单独或联合用于治疗与骨质疏松症相关的高钙尿症:两种药物和三种治疗方案的随机对照试验
Nephrol Dial Transplant. 2009 May;24(5):1472-7. doi: 10.1093/ndt/gfn690. Epub 2008 Dec 15.
6
Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports).
Diabetes Res Clin Pract. 2004 Sep;65(3):243-6. doi: 10.1016/j.diabres.2004.02.005.
7
Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.合理使用利尿剂治疗高血压:俄罗斯ARGUS-2研究结果
Curr Med Res Opin. 2009 Sep;25(9):2229-37. doi: 10.1185/03007990903157531.
8
Treatment of idiopathic hypercalciuria with indapamide.用吲达帕胺治疗特发性高钙尿症。
CMAJ. 1986 Jul 15;135(2):119-21.
9
Antidiuretic effect of indapamide in central diabetes insipidus.吲达帕胺对中枢性尿崩症的抗利尿作用。
Acta Endocrinol (Copenh). 1990 Dec;123(6):657-60. doi: 10.1530/acta.0.1230657.
10
Effects of valsartan and indapamide on plasma cytokines in essential hypertension.缬沙坦和吲达帕胺对原发性高血压患者血浆细胞因子的影响。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Oct;31(5):629-34.